Ticker

Early validation of mycelium-based infection detection and AI-powered MycoLab.ai platform strengthens commercialization outlook and strategic flexibility ESTERO, Fla., March 24, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Mushrooms Inc.

ESTERO, Fla., March 24, 2026 (GLOBE NEWSWIRE) -- Mushrooms Inc. (OTC: MSRM) today announced the successful early-stage validation of its mycelium-based infection detection technology and the completion of beta testing for its MycoLab.ai research platform, marking a significant advancement in the development of its MycoLabX platform.

Treatment-Resistant Depression (TRD) stands as one of the most stubborn and costly challenges in modern healthcare. For the millions of patients who have cycled through multiple antidepressants without relief, the treatment landscape has long been a graveyard of failed promises.

ESTERO, Fla., Jan. 29, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Mushrooms, Inc. (OTC: MSRM), a U.S.

ESTERO, Fla., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Mushrooms, Inc. (OTC: MSRM), a U.S.-based public company, today announced that it has entered into a Share Exchange Agreement to acquire SecurCapital Corp, a Delaware corporation and provider of supply chain logistics and finance solutions headquartered in Los Angeles, California.